Chengzhi Xie

Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells

Xiaojia Niu, Jianyun Zhao, Jun Ma et al. · Clinical Cancer Research · 2016 · 248 citations · Full text

Medicine, Molecular Biology, Oncology +16

Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma

Xundi Xu, Yi Liu, Shengfu Huang et al. · Cancer Genetics and Cytogenetics · 2006 · 168 citations

Medicine, Cancer Biology, Oncology +11

Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51

Chengzhi Xie, Christina D. Drenberg, Holly Edwards et al. · PLoS ONE · 2013 · 94 citations · Full text

Medicine, Oncology, Pharmacology +17

RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia

Holly Edwards, Chengzhi Xie, Katherine M. LaFiura et al. · Blood · 2009 · 89 citations · Full text

Medicine, Cell Biology, Oncology +16

Mechanisms of Synergistic Antileukemic Interactions between Valproic Acid and Cytarabine in Pediatric Acute Myeloid Leukemia

Chengzhi Xie, Holly Edwards, Xuelian Xu et al. · Clinical Cancer Research · 2010 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17